Advanced search
Publication Cover
Scandinavian Journal of Rheumatology Volume 16, 1987 - Issue sup64
Submit an article Journal homepage
53
Views
12
CrossRef citations to date
0
Altmetric
Original Article

The Pharmacokinetics of Sulphasalazine in Young and Elderly Patients with Rheumatoid Arthritis

A. J. Taggart Department of Therapeutics and Pharmacology, Queen's University of Belfast, Belfast, Northern Ireland
,
B. McDermott Department of Therapeutics and Pharmacology, Queen's University of Belfast, Belfast, Northern Ireland
,
M. Delargy Department of Rheumatology, Musgrave Park Hospital, Belfast, Northern Ireland
,
S. Elborn Department of Rheumatology, Musgrave Park Hospital, Belfast, Northern Ireland
,
J. Forbes Department of Rheumatology, Musgrave Park Hospital, Belfast, Northern Ireland
,
S. D. Roberts Bioanalytical Group, Pharmacia AB, Uppsala, Sweden
&
N. O. Ahnfelt Bioanalytical Group, Pharmacia AB, Uppsala, Sweden
 show all
Pages 29-36 | Published online: 12 Jul 2009

References

  • Ahnfelt N-O, Modin R., Odell M-L, Ohlson U. Determination of salicylazosulphapyridine, sulphapyridine and its metabolites in serum and urine. J Pharm Biomed Anal 1986; 4: 261
  • Azad Khan A. K., Howes D. T., Pins J., Truelove S. C. Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis. Gut 1980; 21: 2332
  • Azad Khan A. K., Truelove S. C., Aronson J. K. The disposition and metabolism of sulphasalazine (salicylazosulphapyridine) in man. Br J Clin Pharmacol 1982; 13: 523
  • Crooks J., O'Malley K., Stevenson I. H. Pharmacokinetics in the elderly. Clin Pharmacokinet 1976; 1: 280
  • Das K. M., Dubin R. Clinical pharmacokinetics of sulphasalazine. Clin Pharmacokinet 1976; 1: 406
  • Das K. M., Eastwood M. A., McManus J. P. A., Sircus W. The metabolism of salicylazosulfapyridine in ulcerative colitis. Gut 1973; 14: 631
  • Das K. M., Eastwood M. A., McManus J. P. A., Sircus W. Adverse reactions during salicylazosulfapyridine and the relation with drug metabolism and acetylator phenotype. N Engl J Med 1973; 289: 491
  • Evans D. A. P. An improved and simplified method of detecting the acetylator phenotype. J Med Genet 1969; 6: 405
  • Fischer C., Klotz U. Is plasma level monitoring of sulfasalazine indicated in the treatment of Crohn's disease or ulcerative colitis. Ther Drug Monit 1980; 2: 153
  • Gibaldi M., Perrier D. Pharmacokinetics. 2nd ed. Marcel Dekker, New York 1982; p. 409
  • Van Hees P. A. M. Clinical and pharmacological aspects of sulphasalazine. MD Thesis. Katholieke Universiteit Te Nijmegen, Netherlands 1979
  • Misiewicz J. J., Lennard-Jones J. E., Connell A. M., Baron J. H., Avery Jones F. Controlled trial of sulphasalazine in ulcerative colitis. Lancet 1965; i: 185
  • Neumann V. C., Grindulis K. A., Hubball S., McConkey B., Wright V. Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham Trial. Br Med J 1983; 287: 1089
  • Neumann V. C., Taggart A. J., Le Gallez P., Astbury C., Hill T., Bird H. A. A study to determine the active moiety of sulphasalazine in rheumatoid arthritis. J Rheumatol 1986; 13: 285
  • Pullar T., Hunter J. A., Capell H. A. Sulphasalazine in rheumatoid arthritis: A double-blind comparison of sulphasalazine with placebo and sodium aurothiomalate. Br Med J 1983; 287: 1102
  • Pullar T., Hunter J. A., Capell H. A. Effect of acetylator phenotype on efficacy and toxicity of sulphasalazine in rheumatoid arthritis. Ann Rheum Dis 1985; 44: 831
  • Pullar T., Hunter J. A., Capell H. A. Sulphasalazine in the treatment of rheumatoid arthritis: relationship of dose and serum levels to efficacy. Br J Rheum 1985; 24: 269
  • Pullar T., Hunter J. A., Capell H. A. Which component of sulphasalazine is active in rheumatoid arthritis. Br Med J 1985; 290: 1535
  • Ritschel W. A. Handbook of basic pharmacokinetics. 2nd ed. Drug Intelligence Publications, Hamilton, Illinois 1982; p. 249
  • Schroder H., Campbell D. E. S. Absorption, metabolism, and excretion of salicylazosulfapyridine in man. Clin Pharmacol Ther 1972; 13: 539
  • Svartz N. Salazopyrin, a new sulfanilamide preparation. Acta Med Scand 1942; 110: 577

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.